OIG study on Medicaid drug prices infuriates R.Ph.s
A recent Office of Inspector General study of how much states pay R.Ph.s for Medicaid drugs outrages some industry leaders. "I'm disgusted," said John Coster, VP of the National Association of Chain Drug Stores. "Instead of a real analysis of the program, they restate the obvious, which is that states pay [for Medicaid drugs] differently. With all due respect, it reflects a trend of OIG reports that lack methodological rigor."
Recent Videos
Related Content
How PBMs Impede Pharmacists’ Ability to Perform Clinical Services | APhA 2025
March 31st 2025Article
Antonio Ciaccia, President of 3 Axis Advisors, led a discussion on pharmacy benefit manager reform and how the inability to pass legislation has led to increased financial hardships in community pharmacy.
